CooperCompanies’ Sustainability Push Gains Traction With First-Time Scope 3 Emissions Disclosure

CooperCompanies (NYSE: COO), a leader in vision care and women’s health, this week released its 2025 Corporate Sustainability Report, marking the first time it has publicly shared full Scope 3 emissions data. The report outlines the company’s environmental impact across its value chain, beyond its direct operations.

The report was published in the past week, with multiple industry outlets confirming this new disclosure. Reports by Simply Wall St and Barchart emphasize the significance of including Scope 3 metrics in sustainability efforts. CooperCompanies’ move provides visibility into indirect emissions from its supply chain, product use, and end-of-life disposal—areas critical to comprehensively assessing its environmental footprint.

Scope 3 emissions represent the broadest category of greenhouse gases, typically encompassing activities not directly controlled by the company itself. By reporting these figures for the first time, CooperCompanies joins a growing number of healthcare and consumer-facing firms seeking greener operations.

This development is especially relevant in the vision care and women’s health sectors, where environmental scrutiny is intensifying as consumers and investors demand greater corporate responsibility. Transparency in emissions data could help CooperCompanies strengthen relationships with ESG-focused investors and institutional stakeholders.

It remains to be seen whether CooperCompanies will link its Scope 3 disclosure to formal emission reduction targets or net‑zero commitments. However, the inclusion of this data positions the company as slightly ahead of the curve in its industry, enhancing its ESG profile.

Stock impact: While the stock price data should be viewed separately, CooperCompanies shares (COO) traded at $70.96 as of August 27, 2026, down 1.31% on the day. It is not yet clear whether the new sustainability disclosure influenced that movement.

Investors in CooperCompanies may now monitor future reporting for establishment of clear-cut emission targets or sustainability-linked performance metrics, which could provide concrete indicators of the company’s commitment and progress.

In sum, the company’s first full Scope 3 emissions disclosure in the 2025 sustainability report marks a material step in its ESG journey. It provides new transparency around environmental impacts across its operations and supply chain—an important development for investors, customers, and stakeholders in the healthcare, vision care, and women’s health space.